Diagnostics
The diagnostic market is at a moment of change. New approaches, such as sequencing, are gaining traction; companion diagnostics are driving closer integration with therapy; continuous monitoring is enabling new diagnostic information; and market drivers are demanding low cost distribution of clinical quality data.
Bespoke diagnostics development service
At TTP we bring together world-leading scientists and engineers to deliver cutting-edge diagnostics solutions today – and we have done so for over three decades. We have a proven track record of working at the forefront of technology, inventing disruptive diagnostic systems every day.
We integrate complex processes into easy-to-use and low-cost disposables. We offer clients complementary technologies that ensure they can deliver. We are unrivalled in speed of development, confidence of functionality and of regulatory manufacturability – and we can deliver at scale.
We make sure diagnostics solutions of the future are delivered today.
Why TTP
Delivery
We provide workable solutions to the most challenging diagnostics problems; turning complex lab processes into simple-to-use diagnostics.
Expert
Our interdisciplinary expert biologists and chemists work in consort with engineers, physicists and human factors to rapidly transform initial ideas into marketable products, and invent new technologies, approaches and platforms.
Add Value
We partner with you to achieve a shared goal, focusing on outcomes and added-value through our pragmatic and creative approach.
Fast-track development
Rapid prototyping and system testing has always been a key aspect of TTP’s development services. Functional testing and often assay evolution are undertaken throughout.
World-class facilities
From engineering facilities to molecular biology and class II, cell culture and bioengineering labs to a MEMS cleanroom, we invest in world-class facilities and maintain ISO 13485:2016 accreditation.
Independent Technology Development
We offer clients complementary technologies such as communications and algorithm developments. We also regularly develop technologies that can be customised and used by our clients in the diagnostic market.
Expertise
Instrument design
Concept generation, functional specification, ID, HF
Cartridge design
Workflow integration, microfluidics, modelling, production insight
Biochemical Design
Assay design, refinement, new reagent development
Integrated system and SW development
Cartridge and instrumentation, control, algorithms, UI
Biochemical Development
Testing, refinement integration
Prototyping
Established prototyping facilities to enable instruments and cartridges at medium volumes (up to 100s of instruments and 1000s of cartridges)
Design for manufacture
We can design your system or integrate with other internal or external design partners.
Manufacturing line development
Support in selection, line creation, and knowledge and design transfer for all scales of manufacture.
Regulation
Structured and effective risk management as part of our QMS. ISO13485:2016 accredited and documentation delivery.
Case studies
Reports
A new era in point-of-care diagnostic testing: possibilities and practicalities
Healthcare systems are under pressure from a multiplicity of sometimes confounding factors, such as increasing backlogs created by the COVID-19 pandemic, staff shortages, changing population demographics, rising prevalence of chronic diseases, and the spread of infectious diseases.
For the situation to improve, there needs to be a rethinking of the approach to healthcare management and practices, including how broader use of in vitro diagnostic point-of-care (IVD POC) testing could be used to help better inform treatment decision-making in the acute setting.
To better understand the scope for increased adoption and expansion of POC testing beyond what is currently available, TTP commissioned a survey of UK and US emergency department (ED) based healthcare professionals (HCPs), specifically doctors, nurses, and paramedics.
In this report, we present the survey’s key findings and examine the opportunities and important considerations for IVD POC testing in the United Kingdom and the United States – within the ED as well as the wider community setting.
Download the ‘A new era in point-of-care diagnostic testing report’
News & Insights
ODx point-of-care diagnostic platform for UTI antibiotic susceptibility testing
TTP developing new COVID-19 screening technology to be used by ‘anyone, anywhere’
TTP talks about CoTest on Sky News
Red Box, The Times: Only new testing technology can bridge the gap to a vaccine
TTP plc collaborates with ODx to develop new technology to address antibiotic resistance
TTP plc enters into exclusive licence agreement with DiaSorin to commercialise molecular diagnostics platform
TTP plc Desktop Biology enables development and manufacture of DnaNudge technology
TTP team devises a route to low-cost RNA detection
TTP plc collaborates with Quotient Ltd to transform transfusion diagnostics and beyond
Next-generation sample preparation: Will better nucleic acid extraction unleash biotechnology, life sciences and diagnostics?
Translating spatial biology into tissue diagnostics with inventive technology
Multiplex cytokine measurement: Covid and beyond
The antimicrobial susceptibility testing conundrum
Imaging by the numbers: quantitative imaging for digital pathology
The future of molecular diagnostics: Will isothermal amplification techniques steal PCR’s crown in the close-to-patient era?
Only a ‘click’ away: click chemistry transforms life science applications
Nanopore sensors – Not just for sequencing
Nanomedicine: A golden horizon
DNA Origami: What can we make of it?
Sometimes size DOES matter!
Spotlight on upconversion nanoparticles: finding the right chemistry to make life science applications “click”
Can we imagine a future of personalised medicine based on the analysis of lipids and carbohydrates?
Editing the genomes of superbugs to combat antibiotic resistence
Remote monitoring and telemedicine: a match made in digital health heaven?
Human learning with machine learning: the game of Go and real-life applications
How to develop microfluidics for commercial products
MEMS evolution: from Silicon to Polymers
Key early-stage microfabrication decisions for life science start-ups and SMEs
Reading the signs of migraines with ML: from algorithm to successful product development
IoT Security: In today’s world, military-grade all-round?
